English
简体中文
Total: £ 56.28
Published Date: 2025-05-06 | Pages: 105 | Tables: 110 | Medical Care
The global market for Pharmaceutical Outsourcing Services (CXO) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Lonza Pharmaceuticals
Thermo Fisher
Caterent
Jubilant LifeSciences
Boehringer Ingelheim
Oxford BioMedica
Charles River
WuXi AppTec
He Yuan Biology
GenScript Biotech
Kanglong Chemical
Porton shares
Notai Biotech
Jiuzhou Pharmaceutical
Kai Laiying
Medici
CXO is a pharmaceutical contract outsourcing service, which mainly includes pharmaceutical contract research and development services (CRO) and pharmaceutical contract production services (CDMOCMO). In the process of new drug R&D, through pharmaceutical contract outsourcing, pharmaceutical companies or biotechnology companies entrust drug R&D and production companies to provide professional R&D services, including the development of technical processes required for the production of drugs, the production of APIs and intermediates, and preparation production.
North American market for Pharmaceutical Outsourcing Services (CXO) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pharmaceutical Outsourcing Services (CXO) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Pharmaceutical Outsourcing Services (CXO) in Clinical Stage Projects is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Pharmaceutical Outsourcing Services (CXO) include Lonza Pharmaceuticals, Thermo Fisher, Caterent, Jubilant LifeSciences, Boehringer Ingelheim, Oxford BioMedica, Charles River, IQVIA, Labcorp Drug Development, WuXi AppTec, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Outsourcing Services (CXO), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Outsourcing Services (CXO).
The Pharmaceutical Outsourcing Services (CXO) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical Outsourcing Services (CXO) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Outsourcing Services (CXO) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza Pharmaceuticals
Thermo Fisher
Caterent
Jubilant LifeSciences
Boehringer Ingelheim
Oxford BioMedica
Charles River
IQVIA
Labcorp Drug Development
WuXi AppTec
He Yuan Biology
GenScript Biotech
Kanglong Chemical
Porton shares
Notai Biotech
Jiuzhou Pharmaceutical
Asymchem Laboratories (Tianjin) Co., Ltd.
Shanghai Medicilon Inc.
ChemPartner
AmbioPharm
CordenPharma
Segment by Type
CRO
CMO/CDMO
CSO
Segment by Application
Clinical Stage Projects
Commercialization Stage Projects
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Outsourcing Services (CXO) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Outsourcing Services (CXO) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 CRO
1.2.3 CMO/CDMO
1.2.4 CSO
1.3 Market by Application
1.3.1 Global Pharmaceutical Outsourcing Services (CXO) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical Stage Projects
1.3.3 Commercialization Stage Projects
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Outsourcing Services (CXO) Market Perspective (2020-2031)
2.2 Global Pharmaceutical Outsourcing Services (CXO) Growth Trends by Region
2.2.1 Global Pharmaceutical Outsourcing Services (CXO) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pharmaceutical Outsourcing Services (CXO) Historic Market Size by Region (2020-2025)
2.2.3 Pharmaceutical Outsourcing Services (CXO) Forecasted Market Size by Region (2026-2031)
2.3 Pharmaceutical Outsourcing Services (CXO) Market Dynamics
2.3.1 Pharmaceutical Outsourcing Services (CXO) Industry Trends
2.3.2 Pharmaceutical Outsourcing Services (CXO) Market Drivers
2.3.3 Pharmaceutical Outsourcing Services (CXO) Market Challenges
2.3.4 Pharmaceutical Outsourcing Services (CXO) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Outsourcing Services (CXO) Players by Revenue
3.1.1 Global Top Pharmaceutical Outsourcing Services (CXO) Players by Revenue (2020-2025)
3.1.2 Global Pharmaceutical Outsourcing Services (CXO) Revenue Market Share by Players (2020-2025)
3.2 Global Pharmaceutical Outsourcing Services (CXO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pharmaceutical Outsourcing Services (CXO) Revenue
3.4 Global Pharmaceutical Outsourcing Services (CXO) Market Concentration Ratio
3.4.1 Global Pharmaceutical Outsourcing Services (CXO) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Outsourcing Services (CXO) Revenue in 2024
3.5 Global Key Players of Pharmaceutical Outsourcing Services (CXO) Head office and Area Served
3.6 Global Key Players of Pharmaceutical Outsourcing Services (CXO), Product and Application
3.7 Global Key Players of Pharmaceutical Outsourcing Services (CXO), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Outsourcing Services (CXO) Breakdown Data by Type
4.1 Global Pharmaceutical Outsourcing Services (CXO) Historic Market Size by Type (2020-2025)
4.2 Global Pharmaceutical Outsourcing Services (CXO) Forecasted Market Size by Type (2026-2031)
5 Pharmaceutical Outsourcing Services (CXO) Breakdown Data by Application
5.1 Global Pharmaceutical Outsourcing Services (CXO) Historic Market Size by Application (2020-2025)
5.2 Global Pharmaceutical Outsourcing Services (CXO) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pharmaceutical Outsourcing Services (CXO) Market Size (2020-2031)
6.2 North America Pharmaceutical Outsourcing Services (CXO) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pharmaceutical Outsourcing Services (CXO) Market Size by Country (2020-2025)
6.4 North America Pharmaceutical Outsourcing Services (CXO) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Outsourcing Services (CXO) Market Size (2020-2031)
7.2 Europe Pharmaceutical Outsourcing Services (CXO) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pharmaceutical Outsourcing Services (CXO) Market Size by Country (2020-2025)
7.4 Europe Pharmaceutical Outsourcing Services (CXO) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Outsourcing Services (CXO) Market Size (2020-2031)
8.2 Asia-Pacific Pharmaceutical Outsourcing Services (CXO) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pharmaceutical Outsourcing Services (CXO) Market Size by Region (2020-2025)
8.4 Asia-Pacific Pharmaceutical Outsourcing Services (CXO) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical Outsourcing Services (CXO) Market Size (2020-2031)
9.2 Latin America Pharmaceutical Outsourcing Services (CXO) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pharmaceutical Outsourcing Services (CXO) Market Size by Country (2020-2025)
9.4 Latin America Pharmaceutical Outsourcing Services (CXO) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Outsourcing Services (CXO) Market Size (2020-2031)
10.2 Middle East & Africa Pharmaceutical Outsourcing Services (CXO) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pharmaceutical Outsourcing Services (CXO) Market Size by Country (2020-2025)
10.4 Middle East & Africa Pharmaceutical Outsourcing Services (CXO) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza Pharmaceuticals
11.1.1 Lonza Pharmaceuticals Company Details
11.1.2 Lonza Pharmaceuticals Business Overview
11.1.3 Lonza Pharmaceuticals Pharmaceutical Outsourcing Services (CXO) Introduction
11.1.4 Lonza Pharmaceuticals Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.1.5 Lonza Pharmaceuticals Recent Development
11.2 Thermo Fisher
11.2.1 Thermo Fisher Company Details
11.2.2 Thermo Fisher Business Overview
11.2.3 Thermo Fisher Pharmaceutical Outsourcing Services (CXO) Introduction
11.2.4 Thermo Fisher Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.2.5 Thermo Fisher Recent Development
11.3 Caterent
11.3.1 Caterent Company Details
11.3.2 Caterent Business Overview
11.3.3 Caterent Pharmaceutical Outsourcing Services (CXO) Introduction
11.3.4 Caterent Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.3.5 Caterent Recent Development
11.4 Jubilant LifeSciences
11.4.1 Jubilant LifeSciences Company Details
11.4.2 Jubilant LifeSciences Business Overview
11.4.3 Jubilant LifeSciences Pharmaceutical Outsourcing Services (CXO) Introduction
11.4.4 Jubilant LifeSciences Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.4.5 Jubilant LifeSciences Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Pharmaceutical Outsourcing Services (CXO) Introduction
11.5.4 Boehringer Ingelheim Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Oxford BioMedica
11.6.1 Oxford BioMedica Company Details
11.6.2 Oxford BioMedica Business Overview
11.6.3 Oxford BioMedica Pharmaceutical Outsourcing Services (CXO) Introduction
11.6.4 Oxford BioMedica Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.6.5 Oxford BioMedica Recent Development
11.7 Charles River
11.7.1 Charles River Company Details
11.7.2 Charles River Business Overview
11.7.3 Charles River Pharmaceutical Outsourcing Services (CXO) Introduction
11.7.4 Charles River Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.7.5 Charles River Recent Development
11.8 IQVIA
11.8.1 IQVIA Company Details
11.8.2 IQVIA Business Overview
11.8.3 IQVIA Pharmaceutical Outsourcing Services (CXO) Introduction
11.8.4 IQVIA Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.8.5 IQVIA Recent Development
11.9 Labcorp Drug Development
11.9.1 Labcorp Drug Development Company Details
11.9.2 Labcorp Drug Development Business Overview
11.9.3 Labcorp Drug Development Pharmaceutical Outsourcing Services (CXO) Introduction
11.9.4 Labcorp Drug Development Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.9.5 Labcorp Drug Development Recent Development
11.10 WuXi AppTec
11.10.1 WuXi AppTec Company Details
11.10.2 WuXi AppTec Business Overview
11.10.3 WuXi AppTec Pharmaceutical Outsourcing Services (CXO) Introduction
11.10.4 WuXi AppTec Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.10.5 WuXi AppTec Recent Development
11.11 He Yuan Biology
11.11.1 He Yuan Biology Company Details
11.11.2 He Yuan Biology Business Overview
11.11.3 He Yuan Biology Pharmaceutical Outsourcing Services (CXO) Introduction
11.11.4 He Yuan Biology Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.11.5 He Yuan Biology Recent Development
11.12 GenScript Biotech
11.12.1 GenScript Biotech Company Details
11.12.2 GenScript Biotech Business Overview
11.12.3 GenScript Biotech Pharmaceutical Outsourcing Services (CXO) Introduction
11.12.4 GenScript Biotech Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.12.5 GenScript Biotech Recent Development
11.13 Kanglong Chemical
11.13.1 Kanglong Chemical Company Details
11.13.2 Kanglong Chemical Business Overview
11.13.3 Kanglong Chemical Pharmaceutical Outsourcing Services (CXO) Introduction
11.13.4 Kanglong Chemical Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.13.5 Kanglong Chemical Recent Development
11.14 Porton shares
11.14.1 Porton shares Company Details
11.14.2 Porton shares Business Overview
11.14.3 Porton shares Pharmaceutical Outsourcing Services (CXO) Introduction
11.14.4 Porton shares Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.14.5 Porton shares Recent Development
11.15 Notai Biotech
11.15.1 Notai Biotech Company Details
11.15.2 Notai Biotech Business Overview
11.15.3 Notai Biotech Pharmaceutical Outsourcing Services (CXO) Introduction
11.15.4 Notai Biotech Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.15.5 Notai Biotech Recent Development
11.16 Jiuzhou Pharmaceutical
11.16.1 Jiuzhou Pharmaceutical Company Details
11.16.2 Jiuzhou Pharmaceutical Business Overview
11.16.3 Jiuzhou Pharmaceutical Pharmaceutical Outsourcing Services (CXO) Introduction
11.16.4 Jiuzhou Pharmaceutical Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.16.5 Jiuzhou Pharmaceutical Recent Development
11.17 Asymchem Laboratories (Tianjin) Co., Ltd.
11.17.1 Asymchem Laboratories (Tianjin) Co., Ltd. Company Details
11.17.2 Asymchem Laboratories (Tianjin) Co., Ltd. Business Overview
11.17.3 Asymchem Laboratories (Tianjin) Co., Ltd. Pharmaceutical Outsourcing Services (CXO) Introduction
11.17.4 Asymchem Laboratories (Tianjin) Co., Ltd. Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.17.5 Asymchem Laboratories (Tianjin) Co., Ltd. Recent Development
11.18 Shanghai Medicilon Inc.
11.18.1 Shanghai Medicilon Inc. Company Details
11.18.2 Shanghai Medicilon Inc. Business Overview
11.18.3 Shanghai Medicilon Inc. Pharmaceutical Outsourcing Services (CXO) Introduction
11.18.4 Shanghai Medicilon Inc. Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.18.5 Shanghai Medicilon Inc. Recent Development
11.19 ChemPartner
11.19.1 ChemPartner Company Details
11.19.2 ChemPartner Business Overview
11.19.3 ChemPartner Pharmaceutical Outsourcing Services (CXO) Introduction
11.19.4 ChemPartner Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.19.5 ChemPartner Recent Development
11.20 AmbioPharm
11.20.1 AmbioPharm Company Details
11.20.2 AmbioPharm Business Overview
11.20.3 AmbioPharm Pharmaceutical Outsourcing Services (CXO) Introduction
11.20.4 AmbioPharm Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.20.5 AmbioPharm Recent Development
11.21 CordenPharma
11.21.1 CordenPharma Company Details
11.21.2 CordenPharma Business Overview
11.21.3 CordenPharma Pharmaceutical Outsourcing Services (CXO) Introduction
11.21.4 CordenPharma Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
11.21.5 CordenPharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Pharmaceutical Outsourcing Services (CXO) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of CRO
Table 3. Key Players of CMO/CDMO
Table 4. Key Players of CSO
Table 5. Global Pharmaceutical Outsourcing Services (CXO) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Pharmaceutical Outsourcing Services (CXO) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Pharmaceutical Outsourcing Services (CXO) Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Pharmaceutical Outsourcing Services (CXO) Market Share by Region (2020-2025)
Table 9. Global Pharmaceutical Outsourcing Services (CXO) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Pharmaceutical Outsourcing Services (CXO) Market Share by Region (2026-2031)
Table 11. Pharmaceutical Outsourcing Services (CXO) Market Trends
Table 12. Pharmaceutical Outsourcing Services (CXO) Market Drivers
Table 13. Pharmaceutical Outsourcing Services (CXO) Market Challenges
Table 14. Pharmaceutical Outsourcing Services (CXO) Market Restraints
Table 15. Global Pharmaceutical Outsourcing Services (CXO) Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Pharmaceutical Outsourcing Services (CXO) Market Share by Players (2020-2025)
Table 17. Global Top Pharmaceutical Outsourcing Services (CXO) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Outsourcing Services (CXO) as of 2024)
Table 18. Ranking of Global Top Pharmaceutical Outsourcing Services (CXO) Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Pharmaceutical Outsourcing Services (CXO) Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Pharmaceutical Outsourcing Services (CXO), Headquarters and Area Served
Table 21. Global Key Players of Pharmaceutical Outsourcing Services (CXO), Product and Application
Table 22. Global Key Players of Pharmaceutical Outsourcing Services (CXO), Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pharmaceutical Outsourcing Services (CXO) Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Pharmaceutical Outsourcing Services (CXO) Revenue Market Share by Type (2020-2025)
Table 26. Global Pharmaceutical Outsourcing Services (CXO) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Pharmaceutical Outsourcing Services (CXO) Revenue Market Share by Type (2026-2031)
Table 28. Global Pharmaceutical Outsourcing Services (CXO) Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Pharmaceutical Outsourcing Services (CXO) Revenue Market Share by Application (2020-2025)
Table 30. Global Pharmaceutical Outsourcing Services (CXO) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Pharmaceutical Outsourcing Services (CXO) Revenue Market Share by Application (2026-2031)
Table 32. North America Pharmaceutical Outsourcing Services (CXO) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Pharmaceutical Outsourcing Services (CXO) Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Pharmaceutical Outsourcing Services (CXO) Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Pharmaceutical Outsourcing Services (CXO) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Pharmaceutical Outsourcing Services (CXO) Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Pharmaceutical Outsourcing Services (CXO) Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Pharmaceutical Outsourcing Services (CXO) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Pharmaceutical Outsourcing Services (CXO) Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Pharmaceutical Outsourcing Services (CXO) Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Pharmaceutical Outsourcing Services (CXO) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Pharmaceutical Outsourcing Services (CXO) Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Pharmaceutical Outsourcing Services (CXO) Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Pharmaceutical Outsourcing Services (CXO) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Pharmaceutical Outsourcing Services (CXO) Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Pharmaceutical Outsourcing Services (CXO) Market Size by Country (2026-2031) & (US$ Million)
Table 47. Lonza Pharmaceuticals Company Details
Table 48. Lonza Pharmaceuticals Business Overview
Table 49. Lonza Pharmaceuticals Pharmaceutical Outsourcing Services (CXO) Product
Table 50. Lonza Pharmaceuticals Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
Table 51. Lonza Pharmaceuticals Recent Development
Table 52. Thermo Fisher Company Details
Table 53. Thermo Fisher Business Overview
Table 54. Thermo Fisher Pharmaceutical Outsourcing Services (CXO) Product
Table 55. Thermo Fisher Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
Table 56. Thermo Fisher Recent Development
Table 57. Caterent Company Details
Table 58. Caterent Business Overview
Table 59. Caterent Pharmaceutical Outsourcing Services (CXO) Product
Table 60. Caterent Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
Table 61. Caterent Recent Development
Table 62. Jubilant LifeSciences Company Details
Table 63. Jubilant LifeSciences Business Overview
Table 64. Jubilant LifeSciences Pharmaceutical Outsourcing Services (CXO) Product
Table 65. Jubilant LifeSciences Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
Table 66. Jubilant LifeSciences Recent Development
Table 67. Boehringer Ingelheim Company Details
Table 68. Boehringer Ingelheim Business Overview
Table 69. Boehringer Ingelheim Pharmaceutical Outsourcing Services (CXO) Product
Table 70. Boehringer Ingelheim Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
Table 71. Boehringer Ingelheim Recent Development
Table 72. Oxford BioMedica Company Details
Table 73. Oxford BioMedica Business Overview
Table 74. Oxford BioMedica Pharmaceutical Outsourcing Services (CXO) Product
Table 75. Oxford BioMedica Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
Table 76. Oxford BioMedica Recent Development
Table 77. Charles River Company Details
Table 78. Charles River Business Overview
Table 79. Charles River Pharmaceutical Outsourcing Services (CXO) Product
Table 80. Charles River Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
Table 81. Charles River Recent Development
Table 82. IQVIA Company Details
Table 83. IQVIA Business Overview
Table 84. IQVIA Pharmaceutical Outsourcing Services (CXO) Product
Table 85. IQVIA Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
Table 86. IQVIA Recent Development
Table 87. Labcorp Drug Development Company Details
Table 88. Labcorp Drug Development Business Overview
Table 89. Labcorp Drug Development Pharmaceutical Outsourcing Services (CXO) Product
Table 90. Labcorp Drug Development Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
Table 91. Labcorp Drug Development Recent Development
Table 92. WuXi AppTec Company Details
Table 93. WuXi AppTec Business Overview
Table 94. WuXi AppTec Pharmaceutical Outsourcing Services (CXO) Product
Table 95. WuXi AppTec Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
Table 96. WuXi AppTec Recent Development
Table 97. He Yuan Biology Company Details
Table 98. He Yuan Biology Business Overview
Table 99. He Yuan Biology Pharmaceutical Outsourcing Services (CXO) Product
Table 100. He Yuan Biology Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
Table 101. He Yuan Biology Recent Development
Table 102. GenScript Biotech Company Details
Table 103. GenScript Biotech Business Overview
Table 104. GenScript Biotech Pharmaceutical Outsourcing Services (CXO) Product
Table 105. GenScript Biotech Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
Table 106. GenScript Biotech Recent Development
Table 107. Kanglong Chemical Company Details
Table 108. Kanglong Chemical Business Overview
Table 109. Kanglong Chemical Pharmaceutical Outsourcing Services (CXO) Product
Table 110. Kanglong Chemical Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
Table 111. Kanglong Chemical Recent Development
Table 112. Porton shares Company Details
Table 113. Porton shares Business Overview
Table 114. Porton shares Pharmaceutical Outsourcing Services (CXO) Product
Table 115. Porton shares Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
Table 116. Porton shares Recent Development
Table 117. Notai Biotech Company Details
Table 118. Notai Biotech Business Overview
Table 119. Notai Biotech Pharmaceutical Outsourcing Services (CXO) Product
Table 120. Notai Biotech Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
Table 121. Notai Biotech Recent Development
Table 122. Jiuzhou Pharmaceutical Company Details
Table 123. Jiuzhou Pharmaceutical Business Overview
Table 124. Jiuzhou Pharmaceutical Pharmaceutical Outsourcing Services (CXO) Product
Table 125. Jiuzhou Pharmaceutical Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
Table 126. Jiuzhou Pharmaceutical Recent Development
Table 127. Asymchem Laboratories (Tianjin) Co., Ltd. Company Details
Table 128. Asymchem Laboratories (Tianjin) Co., Ltd. Business Overview
Table 129. Asymchem Laboratories (Tianjin) Co., Ltd. Pharmaceutical Outsourcing Services (CXO) Product
Table 130. Asymchem Laboratories (Tianjin) Co., Ltd. Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
Table 131. Asymchem Laboratories (Tianjin) Co., Ltd. Recent Development
Table 132. Shanghai Medicilon Inc. Company Details
Table 133. Shanghai Medicilon Inc. Business Overview
Table 134. Shanghai Medicilon Inc. Pharmaceutical Outsourcing Services (CXO) Product
Table 135. Shanghai Medicilon Inc. Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
Table 136. Shanghai Medicilon Inc. Recent Development
Table 137. ChemPartner Company Details
Table 138. ChemPartner Business Overview
Table 139. ChemPartner Pharmaceutical Outsourcing Services (CXO) Product
Table 140. ChemPartner Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
Table 141. ChemPartner Recent Development
Table 142. AmbioPharm Company Details
Table 143. AmbioPharm Business Overview
Table 144. AmbioPharm Pharmaceutical Outsourcing Services (CXO) Product
Table 145. AmbioPharm Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
Table 146. AmbioPharm Recent Development
Table 147. CordenPharma Company Details
Table 148. CordenPharma Business Overview
Table 149. CordenPharma Pharmaceutical Outsourcing Services (CXO) Product
Table 150. CordenPharma Revenue in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025) & (US$ Million)
Table 151. CordenPharma Recent Development
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
Table 155. Authors List of This Report
List of Figures
Figure 1. Pharmaceutical Outsourcing Services (CXO) Picture
Figure 2. Global Pharmaceutical Outsourcing Services (CXO) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pharmaceutical Outsourcing Services (CXO) Market Share by Type: 2024 VS 2031
Figure 4. CRO Features
Figure 5. CMO/CDMO Features
Figure 6. CSO Features
Figure 7. Global Pharmaceutical Outsourcing Services (CXO) Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Pharmaceutical Outsourcing Services (CXO) Market Share by Application: 2024 VS 2031
Figure 9. Clinical Stage Projects Case Studies
Figure 10. Commercialization Stage Projects Case Studies
Figure 11. Pharmaceutical Outsourcing Services (CXO) Report Years Considered
Figure 12. Global Pharmaceutical Outsourcing Services (CXO) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Pharmaceutical Outsourcing Services (CXO) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Pharmaceutical Outsourcing Services (CXO) Market Share by Region: 2024 VS 2031
Figure 15. Global Pharmaceutical Outsourcing Services (CXO) Market Share by Players in 2024
Figure 16. Global Top Pharmaceutical Outsourcing Services (CXO) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Outsourcing Services (CXO) as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Pharmaceutical Outsourcing Services (CXO) Revenue in 2024
Figure 18. North America Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Pharmaceutical Outsourcing Services (CXO) Market Share by Country (2020-2031)
Figure 20. United States Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Pharmaceutical Outsourcing Services (CXO) Market Share by Country (2020-2031)
Figure 24. Germany Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Pharmaceutical Outsourcing Services (CXO) Market Share by Region (2020-2031)
Figure 32. China Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Pharmaceutical Outsourcing Services (CXO) Market Share by Country (2020-2031)
Figure 40. Mexico Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Pharmaceutical Outsourcing Services (CXO) Market Share by Country (2020-2031)
Figure 44. Turkey Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Pharmaceutical Outsourcing Services (CXO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Lonza Pharmaceuticals Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
Figure 48. Thermo Fisher Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
Figure 49. Caterent Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
Figure 50. Jubilant LifeSciences Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
Figure 51. Boehringer Ingelheim Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
Figure 52. Oxford BioMedica Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
Figure 53. Charles River Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
Figure 54. IQVIA Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
Figure 55. Labcorp Drug Development Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
Figure 56. WuXi AppTec Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
Figure 57. He Yuan Biology Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
Figure 58. GenScript Biotech Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
Figure 59. Kanglong Chemical Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
Figure 60. Porton shares Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
Figure 61. Notai Biotech Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
Figure 62. Jiuzhou Pharmaceutical Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
Figure 63. Asymchem Laboratories (Tianjin) Co., Ltd. Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
Figure 64. Shanghai Medicilon Inc. Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
Figure 65. ChemPartner Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
Figure 66. AmbioPharm Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
Figure 67. CordenPharma Revenue Growth Rate in Pharmaceutical Outsourcing Services (CXO) Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
